New Delhi, Aug 1 A recent study evaluating the efficacy and safety of Covishield vaccine administered in Delhi's Rajiv Gandhi Cancer Institute and Research Center
Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor